Forte Biosciences Inc (FBRX)
4.75
+0.38
(+8.70%)
USD |
NASDAQ |
Nov 05, 16:00
4.75
0.00 (0.00%)
After-Hours: 16:11
Forte Biosciences Shareholders Equity (Quarterly): 16.96M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.96M |
| March 31, 2024 | 28.68M |
| December 31, 2023 | 35.31M |
| September 30, 2023 | 40.41M |
| June 30, 2023 | 24.88M |
| March 31, 2023 | 32.95M |
| December 31, 2022 | 38.82M |
| September 30, 2022 | 42.84M |
| June 30, 2022 | 38.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 40.05M |
| December 31, 2021 | 41.55M |
| September 30, 2021 | 43.65M |
| June 30, 2021 | 49.91M |
| March 31, 2021 | 54.70M |
| December 31, 2020 | 58.98M |
| September 30, 2020 | 20.32M |
| June 30, 2020 | 24.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.96M
Minimum
Jun 2024
58.98M
Maximum
Dec 2020
37.24M
Average
38.82M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Theriva Biologics Inc | 27.65M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.08M |
| Total Liabilities (Quarterly) | 9.117M |